TegMine Therapeutics
Biotechnology Research • 
South San Francisco, California, United States • 1-10 Employees
Company overview
| Headquarters | South San Francisco, California, United States |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
Key Contacts at TegMine Therapeutics
Jeff Bernstein
Co-Founder / Ceo
Sanjaya Sahoo
Director, Antibody Discovery And Development
Jason Held
Director
TegMine Therapeutics Email Formats
TegMine Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@tegminetx.com), used 80% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@tegminetx.com | 80% |
{first initial} | j@tegminetx.com | 20% |
About TegMine Therapeutics
At Tegmine we target glycoproteins, which are a hallmark of numerous solid cancers and drive aggressive disease. We’ve engineered a system to generate revolutionary new antibody-based therapies for cancer which dramatically increase efficacy while reducing toxic side effects. Our proprietary TegMiner™ platform enables the discovery of unique cancer epitopes and allows us to develop these life-changing new antibodies for patients with unmet needs.
TegMine Therapeutics revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $334,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
TegMine Therapeutics has 3 employees across 3 departments.
Departments
Number of employees
TegMine Therapeutics Tech Stack
Discover the technologies and tools that power TegMine Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Hosting
JavaScript libraries
Israel
Belgium
Switzerland
Italy
Frequently asked questions
4.8
40,000 users
